Functional limitation as a mediator of the link between multimorbidity and health-related quality of life in Australia: evidence from a national panel analysis
File(s)fmed-10-1151310.pdf (404.38 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Objective:
The inverse relationships between chronic disease multimorbidity and health-related quality of life (HRQoL) have been well documented in the literature. However, the mechanism underlying this relationship remains largely unknown. This is the first study to look into the potential role of functional limitation as a mediator in the relationship between multimorbidity and HRQoL.
Method:
This study utilized three recent waves of nationally-representative longitudinal Household, Income and Labour Dynamics in Australia (HILDA) surveys from 2009-2017 (n=6,814). A panel mediation analysis was performed to assess the role of functional limitation as a mediator in the relationship between multimorbidity and HRQoL. The natural direct effect (NDE), indirect effect (NIE), marginal total effect (MTE), and percentage mediated were used to calculate the levels of the mediation effect.
Result:
This study found that functional limitation is a significant mediator in the relationship between multimorbidity and HRQoL. In the logistic regression analysis, the negative impact of multimorbidity on HRQoL was reduced after functional limitation was included in the regression model. In the panel mediation analysis, our results suggested that functional limitation mediated approximately 27.2% (p<0.05) of the link between multimorbidity and the composite SF-36 score for HRQoL. Functional limitation also mediated the relationship between the number of chronic conditions and HRQoL for each of the eight SF-36 dimensions, with a proportion mediated ranging from 18.4 to 28.8% (p<0.05).
Conclusion:
Functional status has a significant impact on HRQoL in multimorbid patients. Treatment should concentrate on interventions that improve patients' functioning and mitigate the negative effects of multimorbidity.
The inverse relationships between chronic disease multimorbidity and health-related quality of life (HRQoL) have been well documented in the literature. However, the mechanism underlying this relationship remains largely unknown. This is the first study to look into the potential role of functional limitation as a mediator in the relationship between multimorbidity and HRQoL.
Method:
This study utilized three recent waves of nationally-representative longitudinal Household, Income and Labour Dynamics in Australia (HILDA) surveys from 2009-2017 (n=6,814). A panel mediation analysis was performed to assess the role of functional limitation as a mediator in the relationship between multimorbidity and HRQoL. The natural direct effect (NDE), indirect effect (NIE), marginal total effect (MTE), and percentage mediated were used to calculate the levels of the mediation effect.
Result:
This study found that functional limitation is a significant mediator in the relationship between multimorbidity and HRQoL. In the logistic regression analysis, the negative impact of multimorbidity on HRQoL was reduced after functional limitation was included in the regression model. In the panel mediation analysis, our results suggested that functional limitation mediated approximately 27.2% (p<0.05) of the link between multimorbidity and the composite SF-36 score for HRQoL. Functional limitation also mediated the relationship between the number of chronic conditions and HRQoL for each of the eight SF-36 dimensions, with a proportion mediated ranging from 18.4 to 28.8% (p<0.05).
Conclusion:
Functional status has a significant impact on HRQoL in multimorbid patients. Treatment should concentrate on interventions that improve patients' functioning and mitigate the negative effects of multimorbidity.
Date Issued
2023-05-17
Date Acceptance
2023-04-25
Citation
Frontiers in Medicine, 2023, 10, pp.1-9
ISSN
2296-858X
Publisher
Frontiers Media S.A.
Start Page
1
End Page
9
Journal / Book Title
Frontiers in Medicine
Volume
10
Copyright Statement
Copyright © 2023 Lee, Ishida, Haregu, Pati, Zhao, Palladino, Anindya, Atun, Oldenburg and Marthias. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
License URL
Identifier
https://www.frontiersin.org/articles/10.3389/fmed.2023.1151310/full
Publication Status
Published
Article Number
1151310
Date Publish Online
2023-05-17